Proton beam therapy for gastrointestinal cancers: past, present, and future

Shahed N. Badiyan(University of Maryland, Baltimore), Michael D. Chuong(Baptist Hospital of Miami), Christopher L. Hallemeier(Mayo Clinic in Arizona), Matthew D. Hall(Baptist Hospital of Miami), Steven H. Lin(The University of Texas MD Anderson Cancer Center)
Journal of Gastrointestinal Oncology
September 29, 2018
10.21037/jgo.2017.11.07
Cited by 26

Related Papers

Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Integrating genomic features for non-invasive early lung cancer detection
|Nature|2020|689
Neuropeptide S
|Neuron|2004|516
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer
|Nature Cancer|2020|369